Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2019.
The company has reported 7.02% rise in its net profit at Rs 268.69 crore for the quarter under review as compared to Rs 251.06 crore for the same quarter in the previous year. Total income of the company increased by 3.44% at Rs 1135.18 crore for Q2FY20 as compared Rs 1097.44 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 23.09% in its net profit at Rs 246.27 crore for the quarter under review as compared to Rs 200.07 crore for the same quarter in the previous year. Total income of the company increased by 9.90% at Rs 1241.23 crore for Q2FY20 as compared Rs 1129.43 crore for the corresponding quarter previous year.
